Tag Archives: LLS-funded research

Our MDS “white knight” moves forward to the finish!

We all like happy endings and this is the best kind! Just last week, rigosertib, a  myelodysplastic syndrome (MDS) drug with tremendous potential, received sizable funding – the kind that will get it across and beyond the finish line. It’s a great story, … Continue reading

Rate this:

Posted in Blood Cancer Research, General SF Chapter | Tagged , , , , , | Leave a comment

Awareness Month Starts Tomorrow

It’s not super well-known, but September is officially blood cancer awareness month (just as October is breast cancer awareness month). This year we are making a concerted effort to help get the word out and invite you to follow our … Continue reading

Rate this:

Posted in General SF Chapter | Tagged | Leave a comment

Wanabe like Gleevec

In 2001, a “magic little pill” called Gleevec changed cancer treatment forever and chronic myeloid leukemia became a managable chronic condition with minimal side effects. Now fast forward to present day; Gleevec has FDA approval for ten different cancers. Think of the number of … Continue reading

Rate this:

Posted in Blood Cancer Research, General SF Chapter, Man & Woman of the Year | Tagged , , , , , | Leave a comment

LLS Research Update: The “why” behind childhood leukemia resistance

A LLS-funded research team at UCSF has discovered the “why” behind the stubborn resistance of acute lymphoblastic leukemia (ALL) cancer cells. It turns out the culprit is a pesky protein that helps leukemia cells stay alive.  When bombarded with powerful cancer drugs, … Continue reading

Rate this:

Posted in Blood Cancer Research, General SF Chapter | Tagged , | Leave a comment